Clinical trial
A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants.
NCT00140673 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00140673 |
|---|---|
| Title | A Study to Test 2 Doses of the HRV Vaccine in Healthy Infants. |
| Official title | A Placebo-controlled, Multi-country & Multi-center Study to Assess the Efficacy, Safety & Immunogenicity of 2 Doses of GSK Biologicals' Oral Live Attenuated Human Rotavirus (HRV) Vaccine in Healthy Infants |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Infections, Rotavirus |
| Intervention type | Biological |
| Interventions | Rotavirus |
| Enrollment | 63,227 |
| Start date | Aug 5, 2003 |
| Completion | Oct 20, 2005 |
| First posted | Sep 1, 2005 |
| Last update posted | Dec 30, 2019 |
| Countries | Argentina, Brazil, Chile, Colombia, Dominican Republic, Finland, Honduras, Mexico, Nicaragua, Panama, Peru, Venezuela |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: